Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration. (2020)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2020.04.078
PubMed Identifier: 32418795
Publication URI: http://europepmc.org/abstract/MED/32418795
Type: Journal Article/Review
Volume: 38
Parent Publication: Vaccine
Issue: 28
ISSN: 0264-410X